NuScale Power Fell 82%. History Says Survivors of Crashes Like This Can Return 5x.

NuScale Power shares have fallen as much as 82% from their October peak, with the stock now around $12 and roughly 76% below its all-time high of $57.42. The article notes that historical 80%-85% drawdowns have seen 49% of stocks recover to prior peaks, but warns NuScale faces real risks, including potential funding shortfalls and an approximately seven-year deployment timeline for SMRs. The piece is cautiously constructive on long-term upside, but emphasizes that the rebound is far from guaranteed.

Analysis

The setup is less about whether the technology is real and more about whether the equity can survive long enough for the technology to matter. In this phase, the biggest loser is not just SMR holders; it is any capital structure that forces the company back to market before a commercial catalyst lands, because dilution risk can cap upside even if sentiment stabilizes. That makes the stock’s path highly dependent on financing conditions over the next 6-18 months, not on the seven-year deployment story that investors are using to justify the thesis.

The second-order winner is the broader AI power chain: established beneficiaries with nearer-term monetization and stronger balance sheets should keep absorbing the narrative premium while speculative nuclear names reset. NVDA still has the cleanest leverage to the AI buildout because it monetizes capex immediately, while SMR represents a long-duration option with substantial execution and funding decay. INTC is a weaker but still positive read-through via the broader “power-constrained AI infrastructure” theme, though it lacks the same direct exposure and may benefit more from sentiment rotation than fundamentals.

The historical drawdown data is directionally useful but probably overstated as a bullish signal because it ignores financing-induced death spirals and the fact that many deep drawdowns are not single-stock “mean reversion” stories but broken business-model stories. For SMR, the market is effectively pricing a probability-weighted outcome between optionality and dilution: if the next 12 months produce no decisive project/financing milestone, the stock can drift into the >90% drawdown regime where recovery odds deteriorate materially. The contrarian view is that this may already be cheap enough for a niche, long-dated speculation basket, but it is not yet investable as a standalone core long without a clear catalyst window.

Key Decisions for Investors

• Avoid outright long SMR here unless you can underwrite a 12-24 month financing runway; the risk/reward is poor because a 20-30% upside bounce can be overwhelmed by another equity raise or sentiment break.
• If expressing the AI power theme, rotate toward NVDA on pullbacks rather than SMR; NVDA has immediate monetization and less binary financing risk, making it a higher-quality way to own the same macro narrative.
• Pair trade idea: long NVDA / short SMR for 3-6 months to isolate the difference between cash-generative AI infrastructure and long-duration speculative power optionality; this should benefit if AI capex stays strong but capital markets get less forgiving.
• For higher-risk accounts, consider a small SMR call spread only after a financing or project milestone, not before; the best entry is on confirmation, because the current setup still has a meaningful dilution tail risk.
• Use SMR weakness as a watchlist candidate rather than a buy-list name; if it approaches a >90% drawdown from peak, reassess only if there is visible capital support or a de-risking catalyst.